Celebrity Inventors
Actor Marlon Brando has four patents, all named "Drumhead tensioning device and method."
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120109677 | BLOOD BANK MANAGEMENT AND RAPID BLOOD TYPE DETERMINATION SYSTEM Disclosed herein is a method for increasing the efficiency and reducing cost of the blood donation, processing and storage by pre-screening candidate donors for blood type and only collecting blood from donors having a needed blood type. Also disclosed are methods and s... | 05/03/2012 |
| 20110318362 | NOVEL CARD PROTEINS INVOLVED IN CELL DEATH REGULATION The present invention provides NB-ARC and CARD-containing proteins (NACs), nucleic acid molecules encoding NACs and antibodies specific for at least one NAC. The invention further provides chimeric NAC proteins. The invention also provides screening assays for identifyi... | 12/29/2011 |
| 20110306065 | USE OF AN ANTIBODY AND A RARE-EARTH BASED CRYSTAL The present invention provides compositions and methods for the detection of red blood cells antigens. The methods and compositions are based on antibodies, serving as primary antibodies or secondary antibodies, that are labeled with a rare-earth based crystal. Methods ... | 12/15/2011 |
| 20110207151 | Utilisation de ferrofluides pour le phenotypage sanguin et applications derivees The invention relates to a method for phenotyping blood and/or performing an irregular agglutinin test and/or for determination of compatibility of a donor and receiver, using an aqueous solution of ferrofluid, obtained from a mixture of polyoxoanions of Fe(III) and at ... | 08/25/2011 |
| 20110189157 | USE OF HUMAN HYALURONIDASES FOR AXONAL REGROWTH Chondroitin sulfate proteoglycans (CS-PGs) are axon growth inhibitory molecules present in the glial scar that are responsible (at least in part) for regeneration failure after CNS or spinal cord injury. Removal of chondroitin sulfate glycosamino-glycan chains using the... | 08/04/2011 |
| 20110177036 | WHOLE BLOOD CULTURES COMPRISING STIMULATED IMMUNE CELLS, AND USE THEREOF AS MEDICAMENTS The present invention relates to a whole-blood culture containing specific immunocompetent killer cells that are activated against tumor cells, viruses, bacteria and/or allergens, whereby the whole-blood culture consists of whole-blood and a culture medium at a ratio of... | 07/21/2011 |
| 20110171666 | PEPTIDE-LIPID CONSTRUCTS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS Peptide-lipid constructs of the structure L-S—F are disclosed, where F is a peptide, S is a spacer covalently linking F to L via an oligomer of ethylene glycol, and L is a diacyl- or dialkyl-glycerolipid (including glycerophospholipids). The spacer ideally has 6 to 14... | 07/14/2011 |
| 20110136152 | SYSTEMS AND METHODS FOR COUNTING CELLS AND BIOMOLECULES The present invention generally relates to systems and methods for counting biomolecules or cells. In certain embodiments, the invention provides a cell counting or biomolecule counting system including: a covered chamber having a known height and configured to hold a s... | 06/09/2011 |
| 20110130303 | IN VITRO DIAGNOSIS/PROGNOSIS METHOD AND KIT FOR ASSESSMENT OF TOLERANCE IN LIVER TRANSPLANTATION In vitro diagnosis/prognosis method and kit, for assessment of tolerance in liver transplantation. The present invention refers to the study of peripheral blood transcriptional patterns from 80 liver transplant recipients and 16 non-transplanted healthy individuals empl... | 06/02/2011 |
| 20110123443 | PANCREATIC BETA-CELL MASS BIOMARKER A biomarker for pancreatic beta-cell mass comprising measuring the levels of CFC1 in the serum of a subject is described. The biomarker provides a noninvasive means for measuring pancreatic beta cell mass that is particularly useful for monitoring the efficacy of treatm... | 05/26/2011 |
| 20110076698 | METHOD OF QUICKLY DETERMINING HUMAN ABO/RH/MN BLOOD TYPE AND A TEST KIT THEREOF A method of quickly determining human ABO/Rh/MN blood type and a test kit thereof. A blood sample to be detected is applied onto a test strip pre-coated with anti-A or anti-B or anti-M or anti-N antibody, a rinse solution is dripped onto one end of the test strip, and t... | 03/31/2011 |
| 20110076697 | LATERAL-FLOW IMMUNO-CHROMATOGRAPHIC ASSAY DEVICES Device including migration membrane, conjugate pad on migration membrane, plasma separation membrane on conjugate pad, pre-filter on plasma separation membrane. Migration membrane has test line configured for loading one or plurality of capture antibodies having specifi... | 03/31/2011 |
| 20110070600 | PARTICLE AGGLUTINATION IN A TIP An apparatus and a related method for performing particle agglutination reactions in at least one disposable probe tip are disclosed. The at least one probe tip includes a sample cavity for sample acquisition, at least one flanking cavity for the capture of particles by... | 03/24/2011 |
| 20100330594 | Early Detection of Diabetes The present invention is based on the discovery that hexosamine, and in particular the dynamic O-GlcNAcylation of proteins (modification of proteins by the sugar N-acetylglucosamine) both causes insulin-resistance (a hallmark of type II diabetes) and is responsible for ... | 12/30/2010 |
| 20100311087 | CELL-BASED ANTIOXIDANT PROTECTION ASSAY Methods are provided herein for determining antioxidant activity of a test sample in intact cells. The method includes determining the antioxidant capacity of a test sample in intact red blood cells, wherein the test sample is added to intact red blood cells and oxidati... | 12/09/2010 |
| 20100311086 | Complement-Mediated Thrombophilic Assay A method for assessing the presence of an acquired thrombophilia disorder in a patient exhibiting hypercoagulation is disclosed.... | 12/09/2010 |
| 20100255510 | RAPID AND SENSITIVE METHOD FOR QUANTITATIVE DETERMINATION OF THE LEVEL OF HEPARIN - PF4 COMPLEX INDUCED IMMUNOGLOBULIN ANTIBODIES Disclosed herein is a lateral flow immuno-assay system capable of rapidly, cost effectively, and quantitatively detecting and assessing the level of HIT antibodies in body fluids of a patient. Also taught are methods for employing the system to assist in diagnosis of HI... | 10/07/2010 |
| 20100255509 | DETECTION OF INFECTIOUS DISEASE IN A HUMAN OR ANIMAL BY MEASURING SPECIFIC PHAGOCYTOSIS IN A THIN FILM SAMPLE OF THEIR ANTICOAGULATED BLOOD A method for performing a target analyte assay of a thin film anticoagulated blood sample, wherein the target analyte is the presence or absence of specific phagocytosis and/or binding of particles coated with a particular antigen or antigens by white blood cells presen... | 10/07/2010 |
| 20100240073 | DETECTION OF FALSE RESULTS IN ASSAYS Methods and reagents are disclosed for detecting a false result in an assay for determining a concentration of an analyte in a whole blood sample suspected of containing the analyte. The method comprises determining by means of the assay a concentration of the analyte u... | 09/23/2010 |
| 20100227337 | Method for Evaluating Risk in Multiple Sclerosis The invention relates to methods and reagents for diagnosing and assessing the prognosis of multiple sclerosis.... | 09/09/2010 |
| 20100221757 | PATIENT SAMPLE CLASSIFICATION BASED UPON LOW ANGLE LIGHT SCATTERING An apparatus for classifying a liquid patient sample includes at least one sample container having a quantity of a sample that is aggressively acted upon so as to create a flow field. A measurement mechanism includes at least one low angle light emitter aligned with a m... | 09/02/2010 |
| 20100216171 | Reducing Time to Result for Blood Bank Diagnostic Testing Methods for reducing time to result in blood bank diagnostic testing with an agitation device and a low ionic strength solution are disclosed. Specifically provided are methods for reducing incubation time for antigen-antibody reactions in an immunohematologic assay by ... | 08/26/2010 |
| 20100184101 | Detection of Antigens Carried by Erythrocytes and of Anti-Erthrocyte Antibodies The invention relates to a method for detecting a plurality of antigenic molecules carried by erythrocytes and/or a plurality of anti-erythrocyte antibodies, said antigenic molecules carried by the erythrocytes consisting of antigenic molecules carried not only by the e... | 07/22/2010 |
| 20100184102 | DEVICE AND METHOD FOR IDENTIFYING AND DETERMINING BLOOD GROUPS A device for the determination and/or the detection of erythrocyte blood groups from a whole blood sample, and a process that implements this device, as well as a kit for the determination and the detection of blood groups are disclosed.... | 07/22/2010 |
| 20100184026 | Companion Diagnostic Assays For Endothelin Receptor Antagonists Methods for identifying cancer patients eligible to receive endothelin receptor antagonist therapy and for monitoring patient response to endothelin receptor antagonist therapy comprise assessment of the expression levels of at least one of PAI-1, uPA, TGFbeta2, IL-6, I... | 07/22/2010 |
| 20100150837 | ANTIBODIES AGAINST GPIb alpha This application relates to agents capable of specifically recognizing GPIbα, a key receptor required for platelet adhesion and aggregation. More specifically, this application relates to monoclonal antibodies and derivatives thereof capable of specifically recognizing... | 06/17/2010 |
| 20100143949 | BIOMARKERS FOR COLORECTAL CANCER Low molecular weight (LMW) peptides have been discovered that are indicative of colorectal cancer. Evaluating patient samples for the presence of such LMW peptides is an effective means of detecting colorectal cancer and monitoring the progression of the disease. The LM... | 06/10/2010 |
| 20100136585 | METHOD AND DEVICE FOR THE DETERMINATION OF MINOR CELL POPULATION IN HETEROGENEOUS CELL POPULATIONS The invention relates to a method for determining one or more cellularly bound analytes in a liquid sample, said method being carried out using a device comprising: at least one feeding zone (5) for applying the liquid sample; a porous membrane (2) that is... | 06/03/2010 |
| 20100061980 | ASSAYS TO PREDICT AND MONITOR ANTIBODY MEDIATED REJECTION OF TRANSPLANTED ALLOGRAFTS The present invention is directed to assays that may be used to measure B cell reactivity to allo or donor antigens in patients, gauge the efficacy of desensitization treatment of these individuals, predict antibody mediated rejection, and monitor patients post transpla... | 03/11/2010 |
| 20100047250 | ACTIVATION EPITOPE OF FCY RII (CD32), BINDING MOLECULES THAT SPECIFICALLY BIND THE EPITOPE AND MEANS AND METHODS FOR THE DETECTION OF THE EPITOPE, AND USES OF SAID EPITOPE OR SAID BINDING MOLECULES The present invention provides means and method for detecting an activation epitope on FcyRII (CD32) on Fcγ (CD32) expressing cells. The presence of epitope on FcγRII (CD32) correlates with priming of the cell containing FcγRII (CD32) expressing said epitope. The inv... | 02/25/2010 |
| 20100041014 | Biological targeting compositions and methods of using the same Modified red blood cells are described. In an embodiment, the modified red blood cell includes a target-binding agent. Targeted delivery of imaging agents, drugs, and peptide and protein pharmaceuticals using modified red blood cells are described. Processes for prepari... | 02/18/2010 |
| 20100041011 | Reference Control for Cell by Cell Analysis A reference control for cell by cell analysis on flow cytometric analyzers contains cellular analogs made of permeated blood cells containing therein aggregated intracellular proteins and preserved antigenic sites thereof, having cellular membrane permeable to antibodie... | 02/18/2010 |
| 20090305311 | C4D/C4B STANDARD FOR QUANTITATIVE FLOW CYTOMETRY OF HUMORAL TRANSPLANT REJECTION The invention concerns an internal standard used to quantitative analysis of the risk of humoral (i.e. vascular) transplant rejection. The internal standard consists of a stable composition of the C4d complement bound to a carrier consisting of erythrocytes or micropart... | 12/10/2009 |
| 20090276863 | Protein formulations comprising s1-5 The present inventors discovered that knockout mice whose S1-5 gene function is lost develop age-related diseases or symptoms. Histological analysis in such knockout mice revealed that bone mineral content, bone mineral density, and bone strength were decreased, and the... | 11/05/2009 |
| 20090252733 | Generation and Profiling of Fully Human Gold-Derived Therapeutic Antibodies Specific for Human CD38 The present invention provides novel antibodies and methods for using recombinant antigen-binding regions and antibodies and functional fragments containing such antigen-binding regions that are specific for CD38, which plays an integral role in various disorders or con... | 10/08/2009 |
| 20090214572 | Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders The invention features methods and compositions for treating and preventing angiogenic disorders and endothelial cells disorders using HspA12B antagonist and HspA12B agonist compounds, respectively.... | 08/27/2009 |
| 20090208981 | Method for Analysis of Interaction Between Small Molecules and Cells and Apparatus thereof A method and an apparatus are provided for analyzing the interaction between small molecules and cells without using density gradient and antibody but using a column packed with identical resin particles. The interactions between cell surface and resin particles resulti... | 08/20/2009 |
| 20090203052 | NOVEL SOLUBLE CD14 ANTIGEN There are provided a soluble CD14 antigen which is a novel in vivo protein useful as a marker for diagnosing sepsis and has the following characteristic features 1) to 3):
| |
| 20090093004 | POTENCY ASSAY The present invention provides a method for determining the in vitro potency of antibodies, in particular anti-Rhesus D positive antibodies. Such antibodies may e.g. be used in the prophylaxis of hemolytic disease of the newborn (HDN), treatment of idiopathic thrombocyt... | 04/09/2009 |
| 20090081711 | ADDRESSABLE ANTIBODY ARRAYS AND METHODS OF USE Systems and assay methods are disclosed for detecting an autoantibody in a sample. In certain instances, the systems and methods employ a mass tag releasably connected to an antigen. The tag is thereafter released for detection. A tag can be detected by mass spectrometr... | 03/26/2009 |
